PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsinvasive hydatidiform mole
MeSH D002820 - invasive hydatidiform mole
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006828:Hydatidiform mole
$
Success rate
D002820: 
Invasive hydatidiform mole
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
75%
30/40
Phase 2
21%
15/70
Phase 3
21%
6/28
Approved: 0Overall Success rate: 3%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use